| scholarly article | Q13442814 |
| P50 | author | Eveline Snelders | Q56452589 |
| Willem Melchers | Q56859383 | ||
| Paul E. Verweij | Q70514014 | ||
| P2093 | author name string | Jan P Arends | |
| Jan W M van der Linden | |||
| Simon M Daenen | |||
| P2860 | cites work | Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism | Q30853962 |
| Efficacy of posaconazole against three clinical Aspergillus fumigatus isolates with mutations in the cyp51A gene. | Q33613758 | ||
| An approach to the diagnosis of pulmonary infections in immunosuppressed patients | Q35532018 | ||
| Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality | Q36715387 | ||
| Azole-resistance in Aspergillus: proposed nomenclature and breakpoints | Q37625111 | ||
| Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles | Q41370116 | ||
| A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. | Q42048818 | ||
| Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure | Q42555868 | ||
| Azole-resistant central nervous system aspergillosis. | Q46094844 | ||
| Improved outcome in central nervous system aspergillosis, using voriconazole treatment | Q46585075 | ||
| Poor efficacy of amphotericin B-based therapy in CNS aspergillosis. | Q52926328 | ||
| Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? | Q61546279 | ||
| Multiple-Triazole–Resistant Aspergillosis | Q63914862 | ||
| Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease | Q74593278 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aspergillosis | Q259626 |
| P304 | page(s) | 1478-1480 | |
| P577 | publication date | 2010-01-27 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Rapid diagnosis of azole-resistant aspergillosis by direct PCR using tissue specimens | |
| P478 | volume | 48 |
| Q90266583 | (New) Methods for Detection of Aspergillus fumigatus Resistance in Clinical Samples |
| Q36094242 | Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing |
| Q47850725 | Azole Resistance in Aspergillus fumigatus in Patients with Cystic Fibrosis: A Matter of Concern? |
| Q28082352 | Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles? |
| Q91912039 | Challenges in the Diagnosis of Invasive Fungal Infections in Immunocompromised Hosts |
| Q47645128 | Chronic Pulmonary Aspergillosis-Where Are We? and Where Are We Going? |
| Q35848799 | Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007-2009. |
| Q30239051 | Clinical implications of globally emerging azole resistance in Aspergillus fumigatus. |
| Q38221673 | Current challenges in the microbiological diagnosis of invasive aspergillosis |
| Q40878593 | Diagnosis and management of aspergillosis in the Netherlands: a national survey |
| Q38165198 | Enhancing molecular approaches for diagnosis of fungal infections |
| Q41846354 | Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain |
| Q38711698 | Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus. |
| Q38222570 | Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms |
| Q35215022 | Incidence of Cyp51 A key mutations in Aspergillus fumigatus-a study on primary clinical samples of immunocompromised patients in the period of 1995-2013 |
| Q37287794 | Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome |
| Q54093034 | Molecular Detection of Azole-Resistant Aspergillus fumigatus in Clinical Samples. |
| Q46307503 | Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species |
| Q41321727 | Multi-triazole-resistant Aspergillus fumigatus infections in Australia |
| Q38400418 | Multilocus sequence typing of Histoplasma capsulatum in formalin-fixed paraffin-embedded tissues from cats living in non-endemic regions reveals a new phylogenetic clade |
| Q55118955 | Performance of Molecular Approaches for Aspergillus Detection and Azole Resistance Surveillance in Cystic Fibrosis. |
| Q37987893 | Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections |
| Q36439193 | Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014. |
| Q37631540 | Screening of the central nervous system in children with invasive pulmonary aspergillosis. |
| Q51697464 | Sinus aspergillosis due to an azole-resistant Aspergillus fumigatus strain carrying the TR34/L98H mutation in immunocompetent host. |
| Q38066615 | The impact of azole resistance on aspergillosis guidelines |
| Q46108058 | Triazole fungicides and the selection of resistance to medical triazoles in the opportunistic mould Aspergillus fumigatus. |
Search more.